Article info
Cancer
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis
- Correspondence to:
Professor R K S Phillips, St Mark's Hospital, Northwick Park, Watford Road, Harrow HA1 3UJ, UK
Citation
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis
Publication history
- Accepted June 20, 2001
- First published June 1, 2002.
Online issue publication
June 01, 2002
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 by Gut